Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of a Personalized Maintenance Therapy Based on the Evolution of Anti-desmoglein Antibodies as Biomarkers of Pemphigus Subclinical Activity, With the Standard Treatment (Rituximab + Corticosteroids) in Pemphigus

NCT05898308 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT05898308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05898308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of a Personalized Maintenance Therapy Based on the Evolution of Anti-desmoglein Antibodies as Biomarkers of Pemphigus Subclinical Activity, With the Standard Treatment (Rituximab + Corticosteroids) in Pemphigus
Lead sponsor
University Hospital, Rouen
Phase
Phase 4
Overall status
Recruiting
Start date
December 4, 2024
Completion date
May 1, 2032
Enrollment
133 (estimated)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

dermatologic disease, pemphigus